For joint health! It has higher effectiveness than glucosamine + chondroitin.
"UC-II" is the trade name for a powdered form of non-denatured type II collagen-containing cartilage extract used as a dietary supplement. It improves joint pain, mobility, and flexibility. It has higher efficacy than glucosamine + chondroitin. It is a newly recognized dietary ingredient that has received GRAS self-certification notification since 2009 and has been published by the FDA. 【Features】 ■ The effect of UC-II intake on alleviating knee arthritis symptoms ■ The efficacy of UC-II in ensuring knee mobility in healthy subjects ■ Improvement in joint pain, mobility, and flexibility ■ Taken in a small amount once a day ■ Unique mechanism of action *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
Related Videos
basic information
【Other Features】 ■ Supply source and manufacturing in the United States ■ Patents - U.S. Patents 9,066,926, 7,846,487, and 7,083,820, European Patent EP 1 435 906, Canadian Patent CA 2459981C, and Japanese Patent JP4800574 B2, along with other granted patents and pending patents ■ Safety profile ■ GRAS self-certification notification obtained since 2009 and published FDA new dietary ingredient (NDI) *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
For over 100 years, our company has provided high-quality hard capsules and unique formulation solutions to customers around the world as a leader in the industry. We have continuously aimed to be a partner in achieving business growth together by responding to your needs through high quality and unwavering trust, and by delivering innovative new products and services. "We believe that all our products and solutions exist for the growth of your business." This is our promise to you. Please look forward to the future of Lonza.
